Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics
- PMID: 11557911
- DOI: 10.1067/mcp.2001.117981
Arterial and venous pharmacokinetics of intravenous heroin in subjects who are addicted to narcotics
Abstract
Background: In Switzerland, medical prescription of heroin (diacetylmorphine) is currently being evaluated as a treatment option for heavily dependent addicts. Therefore the diacetylmorphine pharmacokinetics in opioid-addicted patients was studied.
Methods: Three different diacetylmorphine doses (up to 210 mg) and 20 mg deuterium-labeled morphine (morphine-d3) were administered intravenously to 8 heroin-addicted patients. Arterial and venous plasma samples were collected, and diacetylmorphine, monoacetylmorphine, morphine, morphine-3-glucuronide, morphine-6-glucuronide, and morphine-d3 plasma concentrations were measured by liquid chromatography-mass spectrometry.
Results: Maximal arterial concentrations of diacetylmorphine, monoacetylmorphine, and morphine were 2.4, 5.4, and 1.4 times higher and occurred 2 to 3 minutes earlier than maximal venous concentrations. Venous areas under the concentration-time curves (AUC) of diacetylmorphine and monoacetylmorphine were 35% and 26% lower than arterial AUC values, whereas for morphine the venous AUC was 15% higher. Morphine-3-glucuronide and morphine-6-glucuronide exhibited no arteriovenous differences. AUCs for diacetylmorphine, monoacetylmorphine, and morphine increased linearly with dose. Diacetylmorphine was completely metabolized to morphine. Substantial morphine input into the arterial circulation persisted for up to 90 minutes. The arterial clearances of diacetylmorphine, monoacetylmorphine, and morphine-d3 were 8.7 +/- 2.6, 6.7 +/- 1.6, and 2.3 +/- 0.3 L/min, respectively. The arterial half-lives of diacetylmorphine and morphine-d3 were 2. 4 +/- 0.8 and 88 +/- 21 minutes, respectively.
Conclusions: These data indicate that substantial arteriovenous differences exist for diacetylmorphine and metabolite kinetics, that the pharmacokinetics of diacetylmorphine and metabolites is linear even in the high dose range used by opioid addicts, and that not only diacetylmorphine but also monoacetylmorphine is substantially metabolized peripherally to morphine.
Similar articles
-
Pharmacokinetics of high doses of intramuscular and oral heroin in narcotic addicts.Clin Pharmacol Ther. 2003 Oct;74(4):341-52. doi: 10.1016/S0009-9236(03)00199-1. Clin Pharmacol Ther. 2003. PMID: 14534521 Clinical Trial.
-
Oral diacetylmorphine (heroin) yields greater morphine bioavailability than oral morphine: bioavailability related to dosage and prior opioid exposure.Br J Clin Pharmacol. 2008 Dec;66(6):781-91. doi: 10.1111/j.1365-2125.2008.03286.x. Br J Clin Pharmacol. 2008. PMID: 18945270 Free PMC article.
-
Pharmacokinetics and pharmacodynamics of high doses of pharmaceutically prepared heroin, by intravenous or by inhalation route in opioid-dependent patients.Basic Clin Pharmacol Toxicol. 2006 Jan;98(1):86-96. doi: 10.1111/j.1742-7843.2006.pto_233.x. Basic Clin Pharmacol Toxicol. 2006. PMID: 16433897 Clinical Trial.
-
Development of pharmaceutical heroin preparations for medical co-prescription to opioid dependent patients.Drug Alcohol Depend. 2005 Dec 12;80(3):283-95. doi: 10.1016/j.drugalcdep.2005.04.008. Drug Alcohol Depend. 2005. PMID: 15916865 Review.
-
The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.Drug Alcohol Depend. 2021 Oct 1;227:108984. doi: 10.1016/j.drugalcdep.2021.108984. Epub 2021 Aug 28. Drug Alcohol Depend. 2021. PMID: 34482044
Cited by
-
Stability of heroin, 6-monoacetylmorphine, and morphine in biological samples and validation of an LC-MS assay for delayed analyses of pharmacokinetic samples in rats.J Pharm Biomed Anal. 2013 Feb 23;74:291-7. doi: 10.1016/j.jpba.2012.10.033. Epub 2012 Nov 15. J Pharm Biomed Anal. 2013. PMID: 23245263 Free PMC article.
-
High levels of morphine-6-glucuronide in street heroin addicts.Psychopharmacology (Berl). 2003 Nov;170(2):200-4. doi: 10.1007/s00213-003-1531-x. Epub 2003 May 28. Psychopharmacology (Berl). 2003. PMID: 12774191
-
Pharmacokinetic correlates of the effects of a heroin vaccine on heroin self-administration in rats.PLoS One. 2014 Dec 23;9(12):e115696. doi: 10.1371/journal.pone.0115696. eCollection 2014. PLoS One. 2014. PMID: 25536404 Free PMC article.
-
Population pharmacokinetics of heroin and its major metabolites.Clin Pharmacokinet. 2006;45(4):401-17. doi: 10.2165/00003088-200645040-00005. Clin Pharmacokinet. 2006. PMID: 16584286 Clinical Trial.
-
Necessity and risks of arterial blood sampling in healthy volunteer studies.Clin Pharmacokinet. 2012 Oct 1;51(10):629-38. doi: 10.1007/s40262-012-0001-1. Clin Pharmacokinet. 2012. PMID: 23018527
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical